Overview

Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip

Status:
Terminated
Trial end date:
2010-11-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the analgesic efficacy and safety of tanezumab added on to diclofenac SR in patients with osteoarthritis of the knee or hip currently experiencing partial benefit from, and are tolerating, diclofenac 150 mg/day therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Analgesics
Diclofenac
Tanezumab